Barclays Downgrades Aspen Aerogels to Underweight, Lowers Price Target to $6
Benzinga Newsdesk 1 year ago
NewsDowngradesPrice TargetAnalyst Ratings
Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:ASPN) from Equal-Weight to Underweight and lowers the price target from $7 to $6.
Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:ASPN) from Equal-Weight to Underweight and lowers the price target from $7 to $6.